🇺🇸 FDA

Drug profile · INN

sugammadex sodium

SUGAMMADEX LORIEN

FDA: approved EMA: application withdrawn PMDA: approved V03AB35
US status
approved
Patents linked
0
News articles
0

Quick answer

sugammadex sodium (SUGAMMADEX LORIEN) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN sugammadex sodium
Brand SUGAMMADEX LORIEN
Route INJECTION
Formulation INJECTABLE
ATC code V03AB35
Originator Teva Pharma GmbH

Frequently asked questions

What is sugammadex sodium?

sugammadex sodium (SUGAMMADEX LORIEN) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for sugammadex sodium?

SUGAMMADEX LORIEN is a marketed brand name for sugammadex sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sugammadex sodium?

sugammadex sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.